Skip to main content

Table 1 Demographic and clinical characteristics

From: Tumor infiltrating B-cells are increased in prostate cancer tissue

 

ALL (n = 53)

Mean age ± SD, years

62 ± 6.8

 Race

 

 Caucasian

45 (84.9%)

Other

8 (15.1%)

Mean BMI ± SD, Kg/m2

27.7 ± 3.6

Hypertension

13 (24.5%)

Hypercholesterolemia

15 (28.3%)

Diabetes

5 (9.4%)

Coronary artery disease

4 (7.5%)

5 Alpha-Reductase (Proscar/Avodart)

8 (15.1%)

Primary relative with prostate Ca

17 (32.1%)

Median PSA (IQR), ng/mL

6.2 (4.2–9.8)

Clinical T stage

 

 T1a-c

24 (45.3%)

 T2a-c

25 (47.2%)

 T3a-b

4 (7.5%)

Biopsy Gleason score

 

 ≤ 6

20 (37.7%)

 7

17 (32.1%)

 ≥ 8

16 (30.2%)

D'Amico risk group

 

 Low risk

10 (16.7%)

 Intermediate risk

9 (15.0%)

 High risk

15 (25%)

 Recurrence

26 (43.3%)